Alcohol dependence: after the withdrawal phase. Long-term abstinence: better health and psychosocial status. Psychosocial support for a chronic disorder. Some drugs are useful adjuncts to medical support.
D000077443:Acamprosate; D000427:Alcohol Deterrents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D000428:Alcohol Drinking / Q000188:drug therapy / Q000517:prevention & control / Q000523:psychology / Q000628:therapy*; D019973:Alcohol-Related Disorders / Q000188:drug therapy / Q000517:prevention & control / Q000523:psychology / Q000628:therapy*; D057229:Alcoholics / Q000523:psychology*; D000437:Alcoholism / Q000188:drug therapy / Q000517:prevention & control / Q000523:psychology / Q000628:therapy*; D000927:Anticonvulsants / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D001418:Baclofen / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D003131:Combined Modality Therapy; D004221:Disulfiram / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D005602:France; D005632:Fructose / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use*; D006304:Health Status; D006801:Humans; D009271:Naltrexone / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D011613:Psychotherapy; D016032:Randomized Controlled Trials as Topic; D055502:Secondary Prevention; D012657:Self-Help Groups; D012944:Social Support; D013654:Taurine / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use*; D013695:Temperance; D000077236:Topiramate; D016896:Treatment Outcome
D000427:Alcohol Deterrents; D000927:Anticonvulsants; D000077236:Topiramate; D013654:Taurine; D005632:Fructose; D009271:Naltrexone; D001418:Baclofen; D000077443:Acamprosate; D004221:Disulfiram